ArticleAntimicrobial agents and chemotherapy2026
Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremia.
Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ertapenem combination therapy has been shown to expedite the time to blood culture sterilization among patients with MSSA bacteremia. The purpose of this study was to define what proportion of patients sterilizes blood cultures within 72 h of ertapenem combination treatment initiation. This was a retrospective, multicenter study of patients who received ertapenem combination therapy for MSSA bacteremia. Patients were considered to have rapid blood culture sterilization if blood cultures were negative within 72 h of ertapenem initiation and delayed blood culture sterilization if blood cultures remained positive after 72 h of ertapenem initiation. Of the 304 patients with MSSA bacteremia who received ertapenem for combination treatment, 197 met the inclusion criteria. The median (IQR) time to ertapenem initiation from the time of blood culture obtainment was 4 (3-5) days, and 47% (93/197) had definitive endocarditis. Overall, 85% (167/197) had rapid blood culture sterilization. Patients who had delayed blood culture sterilization had a trend toward a higher Pitt Bacteremia Score at the time of blood culture obtainment (2 [0-4] vs 1 [0-2],
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.